Get the Stockscreener App
0.50
1.38%
-0.007
Fibrogen Inc Stock (FGEN) Latest News
FibroGen Inc: Weathering Stock Market Storms with 51.09M Market Cap - The InvestChronicle
Trading Day Triumph: FibroGen Inc (FGEN) Ends at 0.46, a -2.61 Surge/Plunge - The Dwinnex
FibroGen (NASDAQ:FGEN) Earns Hold Rating from Analysts at StockNews.com - Defense World
JPMorgan Chase & Co. Has $668,000 Position in FibroGen, Inc. (NASDAQ:FGEN) - Defense World
Assenagon Asset Management S.A. Sells 415,812 Shares of FibroGen, Inc. (NASDAQ:FGEN) - Defense World
FibroGen (NASDAQ:FGEN) Share Price Passes Above 50-Day Moving AverageWhat's Next? - MarketBeat
FibroGen Inc (NASDAQ: FGEN) Is Down -5.77% – Can It Revive? - Stocks Register
FibroGen, Inc. (NASDAQ:FGEN) Shares Purchased by Geode Capital Management LLC - Defense World
Perspective Therapeutics Appoints FibroGen Veteran Juan Graham as New CFO to Drive Growth Strategy - StockTitan
State Street Corp Lowers Holdings in FibroGen, Inc. (NASDAQ:FGEN) - Defense World
Cue Biopharma (NASDAQ:CUE) versus FibroGen (NASDAQ:FGEN) Head-To-Head Comparison - Defense World
FibroGen (NASDAQ:FGEN) Coverage Initiated by Analysts at StockNews.com - Defense World
FibroGen (NASDAQ:FGEN) Coverage Initiated at StockNews.com - MarketBeat
Court of Chancery Applies Well-Settled Principles To Dismiss Malone/Caremark ‘Hybrid’ Claims - JD Supra
There's No Escaping FibroGen, Inc.'s (NASDAQ:FGEN) Muted Revenues Despite A 26% Share Price Rise - Simply Wall St
FibroGen (NASDAQ:FGEN) Now Covered by Analysts at StockNews.com - Defense World
Recent Investment Analysts’ Ratings Updates for FibroGen (FGEN) - Defense World
Fmr LLC Boosts Holdings in FibroGen, Inc. (NASDAQ:FGEN) - Defense World
HC Wainwright Comments on FibroGen FY2024 Earnings - Defense World
HC Wainwright Upgrades FibroGen (NASDAQ:FGEN) to Strong-Buy - Defense World
HC Wainwright Estimates FibroGen FY2026 Earnings - Defense World
FibroGen started at buy by H.C. Wainwright (FGEN:NASDAQ) - Seeking Alpha
FibroGen shares rating initiated with Buy on product potential By Investing.com - Investing.com Canada
FibroGen appoints David DeLucia CFO - MSN
FibroGen shares rating initiated with Buy on product potential - Investing.com
FibroGen names David DeLucia as new CFO By Investing.com - Investing.com Canada
FibroGen Appoints David DeLucia as CFO - TipRanks
FibroGen, Inc. Appoints David DeLucia as Chief Financial Officer - Marketscreener.com
FibroGen names David DeLucia as new CFO - Investing.com
FibroGen Appoints David DeLucia as Chief Financial Officer - GlobeNewswire
FibroGen Names David DeLucia as New CFO to Lead Financial Strategy and Drug Development Push - StockTitan
FibroGen (NASDAQ:FGEN) Now Covered by StockNews.com - Defense World
Analyzing Unicycive Therapeutics (NASDAQ:UNCY) and FibroGen (NASDAQ:FGEN) - Defense World
FibroGen Inc earnings beat by $0.14, revenue topped estimates - Investing.com Nigeria
Idiopathic Pulmonary Fibrosis Market Report 2034, by DelveInsight | Companies: FibroGen, Hoffmann-La Roche Ltd, United Therapeutics, Boehringer Ingelheim, Pliant Therapeutics, Inc., Galecto Biotech - The Globe and Mail
StockNews.com Begins Coverage on FibroGen (NASDAQ:FGEN) - Defense World
ARMISTICE CAPITAL, LLC Reduces Stake in FibroGen Inc - GuruFocus.com
FibroGen Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
FGEN stock touches 52-week low at $0.19 amid market challenges - Investing.com India
FibroGen, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
FibroGen, Inc. (NASDAQ:FGEN) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: FibroGen reports strong Q3 sales, advances in oncology pipeline - Investing.com UK
FibroGen: Q3 Earnings Snapshot - mySA
FibroGen Inc (FGEN) Q3 2024 Earnings Call Highlights: Strong Rev - GuruFocus.com
FibroGen (FGEN) Reports Q3 Loss, Tops Revenue Estimates - MSN
FibroGen Inc (FGEN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Cost Reductions - Yahoo Finance
FibroGen Inc (FGEN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Cost Reductions By GuruFocus - Investing.com Canada
0.82%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):